Acutaas Chemicals Limited (BOM:543349)
India · Delayed Price · Currency is INR 2,016.25
-78.75 (-3.76%)
At close: Feb 13, 2026
Acutaas Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 12,151 | 10,069 | 7,175 | 6,167 | 5,201 | 3,406 |
Revenue | 12,151 | 10,069 | 7,175 | 6,167 | 5,201 | 3,406 |
Revenue Growth (YoY) | 31.60% | 40.34% | 16.33% | 18.57% | 52.71% | 42.13% |
Cost of Revenue | 5,742 | 5,624 | 4,159 | 3,348 | 2,762 | 1,814 |
Gross Profit | 6,409 | 4,445 | 3,016 | 2,819 | 2,439 | 1,592 |
Selling, General & Admin | 1,079 | 839.75 | 633.91 | 492.13 | 417.35 | 213.79 |
Other Operating Expenses | 1,511 | 1,284 | 1,097 | 1,093 | 970.26 | 572.27 |
Operating Expenses | 2,927 | 2,390 | 1,891 | 1,709 | 1,488 | 827.93 |
Operating Income | 3,482 | 2,055 | 1,124 | 1,110 | 950.95 | 764.26 |
Interest Expense | -26.82 | -62.18 | -59.4 | -24.12 | -64.07 | -52 |
Interest & Investment Income | 107.96 | 107.96 | 21.32 | 21.79 | 25.82 | 3.59 |
Currency Exchange Gain (Loss) | 61.19 | 61.19 | 41.89 | 21.32 | 1.32 | 6.59 |
Other Non Operating Income (Expenses) | 193.24 | - | 9.62 | 0.09 | 0.49 | -0.57 |
EBT Excluding Unusual Items | 3,817 | 2,161 | 1,138 | 1,129 | 914.5 | 721.87 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -3.24 |
Gain (Loss) on Sale of Assets | 0.14 | 0.14 | 2.08 | -7.47 | - | -0.18 |
Other Unusual Items | - | - | -320.84 | - | - | -1.19 |
Pretax Income | 3,818 | 2,162 | 819.01 | 1,122 | 914.5 | 717.26 |
Income Tax Expense | 969.57 | 557.45 | 331.93 | 288.82 | 195.04 | 177.27 |
Earnings From Continuing Operations | 2,848 | 1,604 | 487.08 | 832.9 | 719.46 | 539.99 |
Minority Interest in Earnings | 21.76 | -17.04 | -59.35 | - | - | - |
Net Income | 2,870 | 1,587 | 427.73 | 832.9 | 719.46 | 539.99 |
Net Income to Common | 2,870 | 1,587 | 427.73 | 832.9 | 719.46 | 539.99 |
Net Income Growth | 136.43% | 271.06% | -48.65% | 15.77% | 33.24% | 96.57% |
Shares Outstanding (Basic) | 82 | 80 | 73 | 73 | 68 | 63 |
Shares Outstanding (Diluted) | 83 | 80 | 73 | 73 | 68 | 63 |
Shares Change (YoY) | -8.75% | 9.26% | 0.63% | 6.53% | 8.59% | - |
EPS (Basic) | 34.84 | 19.81 | 5.83 | 11.43 | 10.52 | 8.57 |
EPS (Diluted) | 34.76 | 19.81 | 5.83 | 11.43 | 10.51 | 8.57 |
EPS Growth | 159.14% | 239.77% | -48.99% | 8.70% | 22.70% | 96.56% |
Free Cash Flow | - | -763 | -1,895 | -128.19 | -456.93 | -791.54 |
Free Cash Flow Per Share | - | -9.52 | -25.84 | -1.76 | -6.68 | -12.56 |
Dividend Per Share | - | 1.500 | 3.000 | 1.500 | 1.500 | - |
Dividend Growth | - | -50.00% | 100.00% | - | - | - |
Gross Margin | 52.74% | 44.14% | 42.03% | 45.71% | 46.90% | 46.75% |
Operating Margin | 28.66% | 20.41% | 15.67% | 18.00% | 18.28% | 22.44% |
Profit Margin | 23.62% | 15.76% | 5.96% | 13.51% | 13.83% | 15.85% |
Free Cash Flow Margin | - | -7.58% | -26.41% | -2.08% | -8.79% | -23.24% |
EBITDA | 3,821 | 2,314 | 1,278 | 1,229 | 1,046 | 806.14 |
EBITDA Margin | 31.44% | 22.98% | 17.81% | 19.93% | 20.11% | 23.67% |
D&A For EBITDA | 338.8 | 259.45 | 153.66 | 119.12 | 95.2 | 41.88 |
EBIT | 3,482 | 2,055 | 1,124 | 1,110 | 950.95 | 764.26 |
EBIT Margin | 28.66% | 20.41% | 15.67% | 18.00% | 18.28% | 22.44% |
Effective Tax Rate | 25.40% | 25.79% | 40.53% | 25.75% | 21.33% | 24.71% |
Revenue as Reported | 12,514 | 10,238 | 7,250 | 6,211 | 5,229 | 3,420 |
Advertising Expenses | - | - | - | - | - | 0.68 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.